Q1/2024 3/31/2024 EPS -0.730 ZacksConsensus -0.260 ActVsEst (0.470) - Miss
Avita Medical, Inc. (RCEL)
Company Research
Source: Wall Street Horizon
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New ZealandGlobeNewswire
- AVITA Medical, Inc. (NASDAQ:RCEL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year [Yahoo! Finance]Yahoo! Finance
- AVITA Medical, Inc. (NASDAQ: RCEL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $12.00 price target on the stock, up previously from $9.00.MarketBeat
- AVITA Medical to Host Investor Webinar BriefingGlobeNewswire
RCEL
Earnings
- 11/7/24 - Miss
RCEL
Sec Filings
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- 8/20/24 - Form 4
- RCEL's page on the SEC website